CBD and Seizures: New Clinical Evidence Challenges Common Beliefs

CBD and Seizures: New Clinical Evidence Challenges Common Beliefs   Introduction CBD and seizures research has skyrocketed in recent years, challenging traditional treatment paradigms for refractory epilepsy. Epilepsy affects approximately 50 million people globally, according to the World Health Organization (WHO). This neurological disorder, previously limited

Epilepsy And The Effectiveness Of Cannabidiol Therapy

Epilepsy And The Effectiveness Of Cannabidiol Therapy There's a growing interest in the potential medical uses of cannabidiol (CBD), a non-psychoactive compound found in cannabis. CBD has been studied for its various effects, and it has shown promise in reducing seizures, particularly in children with drug-resistant epilepsy. CBD's Phase III studies showed

Ganaxolone Treatment For Refractory Epilepsy

Ganaxolone Treatment For Refractory Epilepsy Overview In a meta-analysis conducted to evaluate the use of ganaxolone for refractory epilepsy, researchers collected data from four randomized controlled trials involving a total of 659 patients. The analysis revealed that ganaxolone significantly improved the reduction in mean seizure frequency by ≥50% when compared to a

CBD and Seizures: New Clinical Evidence Challenges Common Beliefs